NCT06700564View on ClinicalTrials.gov

The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Hepatoma
Interventions
OTHER

PET scan of FDG

The enrolled patients will undergo PET examination, and the radiation dose generated during the examination will not cause physiological damage to the patients

All Listed Sponsors
lead

Shanghai East Hospital

OTHER

NCT06700564 - The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/CT and Enhanced MRI in Hepatic Malignancies | Biotech Hunter | Biotech Hunter